REFERENCES

1. Feng Y, Guo X, Yang Y, Qiu W, Chen Z, Fang F. Noncoding RNAs in periodontitis: progress and perspectives (Review). Int J Mol Med. 2025;56:1-17.

2. Larsson L, Kavanagh NM, Nguyen TVN, Castilho RM, Berglundh T, Giannobile WV. Influence of epigenetics on periodontitis and peri-implantitis pathogenesis. Periodontol 2000. 2022;90:125-37.

3. Hathaway-Schrader JD, Novince CM. Maintaining homeostatic control of periodontal bone tissue. Periodontol 2000. 2021;86:157-87.

4. Villoria GEM, Fischer RG, Tinoco EMB, Meyle J, Loos BG. Periodontal disease: a systemic condition. Periodontol 2000. 2024;96:7-19.

5. Balta MG, Papathanasiou E, Blix IJ, Van Dyke TE. Host modulation and treatment of periodontal disease. J Dent Res. 2021;100:798-809.

6. Larsson L, Giraldo-Osorno PM, Garaicoa-Pazmino C, Giannobile WV, Asa'ad F. DNA and RNA methylation in periodontal and peri-implant diseases. J Dent Res. 2025;104:131-9.

7. Sendinc E, Shi Y. RNA m6A methylation across the transcriptome. Mol Cell. 2023;83:428-41.

8. Sun H, Li K, Liu C, Yi C. Regulation and functions of non-m⁶A mRNA modifications. Nat Rev Mol Cell Biol. 2023;24:714-31.

9. Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169:1187-200.

10. Zhang L, Wei J, Zou Z, He C. RNA modification systems as therapeutic targets. Nat Rev Drug Discov. 2026;25:59-78.

11. Lin LC, Liu ZY, Yang JJ, Zhao JY, Tao H. m6A epitranscriptomic modification in diabetic microvascular complications. Trends Pharmacol Sci. ;2023:991-1008.

12. Feng G, Wu Y, Hu Y, et al. Small molecule inhibitors targeting m⁶A regulators. J Hematol Oncol. 2024;17:30.

13. Oerum S, Meynier V, Catala M, Tisné C. A comprehensive review of m6A/m6Am RNA methyltransferase structures. Nucleic Acids Res. 2021;49:7239-55.

14. Shi H, Wang X, Lu Z, et al. YTHDF3 facilitates translation and decay of N⁶-methyladenosine-modified RNA. Cell Res. 2017;27:315-28.

15. Roundtree IA, Luo GZ, Zhang Z, et al. YTHDC1 mediates nuclear export of N⁶-methyladenosine methylated mRNAs. Elife. 2017;6:e31311.

16. Wang Y, Zhang X, Yang F, Shang J, Yang Q. METTL3-mediated m⁶A modification of pri-miR-93 promotes hepatocellular carcinoma progression via CDKN1A suppression. Cancer Genet. 2025;296-297:31-40.

17. Roshan M K, Pal R, Kumari S, Kumar S, Muthuswamy S. The interplay of N6-methyladenosine and ferroptosis in cancer: a promising therapeutic avenue. Cancer Genet. 2025;296-297:15-24.

18. Sun X, Meng X, Piao Y, Dong S, Dong Q. METTL3 promotes the osteogenic differentiation of human periodontal ligament cells by increasing YAP activity via IGF2BP1 and YTHDF1-mediated m⁶A modification. J Periodontal Res. 2024;59:1017-30.

19. Zhou X, Yang X, Huang S, et al. Inhibition of METTL3 alleviates NLRP3 inflammasome activation via increasing ubiquitination of NEK7. Adv Sci (Weinh). 2024;11:e2308786.

20. Ma XX, Zhou XY, Feng MG, et al. Dual role of IGF2BP2 in osteoimmunomodulation during periodontitis. J Dent Res. 2024;103:208-17.

21. Lin W, Xu H, Wu Y, Wang J, Yuan Q. In silico genome-wide identification of m6A-associated SNPs as potential functional variants for periodontitis. J Cell Physiol. 2020;235:900-8.

22. Zhang X, Zhang S, Yan X, et al. m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis. J Cell Mol Med. 2021;25:3634-45.

23. Wang Z, Chen H, Peng L, He Y, Wei J, Zhang X. DNER and GNL2 are differentially m6A methylated in periodontitis in comparison with periodontal health revealed by m6A microarray of human gingival tissue and transcriptomic analysis. J Periodontal Res. 2023;58:529-43.

24. Zou X, Liu C, Wu X, Yuan Z, Yan F. Changes in N6-methyladenosine RNA methylomes of human periodontal ligament cells in response to inflammatory conditions. J Periodontal Res. 2023;58:444-55.

25. Sun X, Meng X, Piao Y, Dong S, Dong Q. METTL3 promotes osteogenic differentiation of human periodontal ligament stem cells through IGF2BP1-mediated regulation of Runx2 stability. Int J Med Sci. 2024;21:664-73.

26. Huang J, Guo C, Wang Y, Zhou Y. Role of N6-adenosine-methyltransferase subunits METTL3 and METTL14 in the biological properties of periodontal ligament cells. Tissue Cell. 2023;82:102081.

27. Yao C, Xin H, Liu S, et al. Role of METTL3-mediated m6A modification in osteogenic differentiation of periodontal ligament stem cells extracted from adult periodontal ligaments ex-vivo. Cell Mol Biol (Noisy-le-grand). 2023;69:23-8.

28. Zhou S, Zhang G, Wang K, Yang Z, Tan Y. METTL3 potentiates osteogenic differentiation of bone marrow mesenchymal stem cells via IGF2BP1/m6A/RUNX2. Oral Dis. 2024;30:1313-21.

29. Zhang X, Liu J, Gao J, et al. N6-methyladenosine promotes osteogenic differentiation of PDLSCs from periodontitis patients. Oral Dis. 2024;30:1322-36.

30. Chen X, Qin Y, Wang X, et al. METTL3-mediated m6A modification regulates the osteogenic differentiation through LncRNA CUTALP in periodontal mesenchymal stem cells of periodontitis patients. Stem Cells Int. 2024;2024:3361794.

31. Li W, Alimujiang A. METTL3 promotes osteogenic differentiation of human periodontal ligament stem cells under the inflammatory microenvironment through the miR-141-3p/ZEB1 axis. Cell Biochem Biophys. 2025;83:1771-83.

32. Huang J, Wang Y, Zhou Y. METTL3 and METTL14 regulate IL-6 expression via RNA m6A modification of zinc transporter SLC39A9 and DNA methylation of IL-6 in periodontal ligament cells. Biochim Biophys Acta Mol Cell Res. 2024;1871:119605.

33. Li Y, Yang Y, Niu Y, et al. The role of WTAP in regulating macrophage-mediated osteoimmune responses and tissue regeneration in periodontitis. Front Immunol. 2024;15:1423378.

34. Xiong M, Wang T, Liu Y. WTAP Contributes to periodontitis pathogenesis by promoting PDLSC senescence and impairing osteogenic differentiation via m6A-dependent regulation of TP53BP1. Immun Inflamm Dis. 2026;14:e70335.

35. Ray SK, Mukherjee S. Exploring replication stress and cellular senescence as key targets in novel cancer therapies. Cancer Genet. 2025;298-299:78-87.

36. Qian Y, Wu J, Yang W, et al. FTO-associated osteoclastogenesis promotes alveolar bone resorption in apical periodontitis male rat via the HK1/USP14/RANK pathway. Nat Commun. 2025;16:1519.

37. He J, Zhao Y, Zhang Y, Zhang Z, Li D, Xu Q. FTO regulates osteoclast development by modulating the proliferation and apoptosis of osteoclast precursors in inflammatory conditions. Cell Signal. 2024;117:111098.

38. Li B, Du M, Sun Q, Cao Z, He H. m⁶ A demethylase Fto regulates the TNF-α-induced inflammatory response in cementoblasts. Oral Dis. 2023;29:2806-15.

39. Zhang Y, Li J, Chen M, Zhang N, Yu X, Wen Y. ALKBH5 promotes inflammation and inhibits osteogenic differentiation by activating the TLR9/MAPK pathway in human periodontal ligament stem cells. Cytotechnology. 2026;78:21.

40. Tan D, Li Q, Chen Z, et al. YTHDC1 Modulates the osteogenic capacity of hPDLSCs via Wnt/β-catenin signalling pathway for the treatment of bone defects in osteoporosis rats. Cell Prolif. 2025;58:e70020.

41. Shao W, Zhao H, Zhang S, et al. A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment. Front Oncol. 2022;12:1049183.

42. Botelho J, Singh S, Varenne B, et al. Oral health and diabetes: a systematic review and meta-analysis. Lancet Public Health. 2026;11:e555-66.

43. Zhou J, Zhu Y, Ai D, et al. Advanced glycation end products impair bone marrow mesenchymal stem cells osteogenesis in periodontitis with diabetes via FTO-mediated N⁶-methyladenosine modification of sclerostin. J Transl Med. 2023;21:781.

44. Zhou J, Li X, Xiao L, Zhu Y, Yang Y, Gao X. Hyperglycemia disrupts alveolar bone homeostasis by inducing stem cell senescence through Mettl3/Foxo3/Sirt1 axis in diabetic periodontitis. Life Sci. 2026;388:124215.

45. Yang Q, Xiao J, Liu Y, et al. METTL3-mediated m6A modifications of NLRP3 accelerate alveolar bone resorption through enhancing macrophage pyroptosis. Cell Signal. 2025;127:111572.

46. Wubulikasimu Z, Zhao H, Mao F, Zhao X. Emerging roles of RNA N4-acetylcytidine modification in reproductive health. Protein Cell. 2025;16:458-77.

47. Zhang Y, Lei Y, Dong Y, et al. Emerging roles of RNA ac4C modification and NAT10 in mammalian development and human diseases. Pharmacol Ther. 2024;253:108576.

48. Ouyang W, Huang Z, Wan K, Nie T, Chen H, Yao H. RNA ac⁴C modification in cancer: unraveling multifaceted roles and promising therapeutic horizons. Cancer Lett. 2024;601:217159.

49. Cui Z, Xu Y, Wu P, et al. NAT10 promotes osteogenic differentiation of periodontal ligament stem cells by regulating VEGFA-mediated PI3K/AKT signaling pathway through ac4C modification. Odontology. 2023;111:870-82.

50. Yang R, Yu W, Lin L, et al. NAT10 promotes osteoclastogenesis in inflammatory bone loss by catalyzing Fos mRNA ac4C modification and upregulating MAPK signaling pathway. J Adv Res. 2025;72:303-17.

51. Chen X, Cheng Q, Gong F, Zheng H. Protein post-translational modification-mediated control of type I interferon cascade signaling. Medicine Bulletin. 2025;1:37-59.

52. Zhang Z, Zhang Y, Cai Y, et al. NAT10 regulates the LPS-induced inflammatory response via the NOX2-ROS-NF-κB pathway in macrophages. Biochim Biophys Acta Mol Cell Res. 2023;1870:119521.

53. Jin H, Shi Z, Zhou T, Xie S. Regulation of m6Am RNA modification and its implications in human diseases. J Mol Cell Biol. 2024;16:mjae012.

54. Liu WW, Zheng SQ, Li T, et al. RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy. Signal Transduct Target Ther. 2024;9:70.

55. Vignon M, Bastide A, Attina A, et al. Multiplexed LC-MS/MS quantification of salivary RNA modifications in periodontitis. J Periodontal Res. 2023;58:959-67.

56. Song W, Liu L, Liang H, et al. m⁶Am methyltransferase PCIF1 regulates periodontal inflammation. J Dent Res. 2024;103:1130-40.

57. Luo Y, Yao Y, Wu P, Zi X, Sun N, He J. The potential role of N⁷-methylguanosine (m7G) in cancer. J Hematol Oncol. 2022;15:63.

58. Wu Q, Fu X, Liu G, He X, Li Y, Ou C. N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential. J Hematol Oncol. 2025;18:12.

59. Zhao C, Li K, Wu A. METTL1-mediated m7G modification regulates osteogenic differentiation of human periodontal ligament stem cells. Clinics (Sao Paulo). 2025;80:100813.

60. Mao Z, Tian Y, Wu L, Zhang Y. Epitranscriptomic mechanisms and implications of RNA m⁵C modification in cancer. Theranostics. 2025;15:8404-28.

61. Xiao L, Wu D, Zhang T, He C, Guo X, Yang H. NSUN2 methylates IRF4 to affect the capacity of macrophages attached to titanium implant on osteogenic differentiation of PDLSCs and angiogenesis of HUVECs in vitro. BMC Oral Health. 2024;24:1371.

62. Liu Y, Zhang S, Gao X, Ru Y, Gu X, Hu X. Research progress of N1-methyladenosine RNA modification in cancer. Cell Commun Signal. 2024;22:79.

63. Wang X, Ma X, Chen S, et al. Harnessing m1A modification: a new frontier in cancer immunotherapy. Front Immunol. 2024;15:1517604.

64. Wang K, Wang A, Qiu L, Xu L, Wei J. Combined bioinformatics and experimental validation identifies m1A-modified genes as potential diagnostic biomarkers in periodontitis and diabetes. Arch Oral Biol. 2025;180:106428.

65. Liao H, Ma H, Meng H, Kang N, Wang L. Ropinirole suppresses LPS-induced periodontal inflammation by inhibiting the NAT10 in an ac4C-dependent manner. BMC Oral Health. 2024;24:510.

66. Chen X, Lin Z, Lei H, et al. An Intelligent MXene nanoplatform for bone regeneration in periodontitis through synergistic scavenging pathogenic cfDNA and ROS. Adv Healthc Mater. 2026;15:e05749.

67. Zhu H, Cai C, Yu Y, et al. Quercetin-loaded bioglass injectable hydrogel promotes m6A alteration of Per1 to alleviate oxidative stress for periodontal bone defects. Adv Sci (Weinh). 2024;11:e2403412.

68. Li L, Wang Y, Gao L, Wu S, Jin Y. Curcumin-carbon dots suppress periodontitis via regulating METTL3/IRE1α signaling. Crit Rev Eukaryot Gene Expr. 2025;35:25-35.

69. Liu C, Sun H, Yi Y, et al. Absolute quantification of single-base m⁶A methylation in the mammalian transcriptome using GLORI. Nat Biotechnol. 2023;41:355-66.

70. Hu L, Liu S, Peng Y, et al. m⁶A RNA modifications are measured at single-base resolution across the mammalian transcriptome. Nat Biotechnol. 2022;40:1210-9.